Month: June 2020

You want to be more productive. I’m here to help you do just that. Here are the 5 foundations of productivity that will help you get more done in less time. 💌 Sign up for my weekly newsletter – https://medschoolinsiders.com/newsletter 🌍 Website & blog – https://medschoolinsiders.com 📸 Instagram – https://instagram.com/medschoolinsiders 🐦 Twitter – https://twitter.com/medinsiders 🗣️
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 30 2020 Using an in-home portable air cleaner (PAC) can significantly reduce exposure to fine-particle air pollutants – a major risk factor for cardiovascular events in people with pre-existing heart disease, reports a pilot study in the July issue of Journal of Cardiopulmonary Rehabilitation and Prevention. The journal is published
0 Comments
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer Print this page South San Francisco, CA — June 29, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination (FDC) of Perjeta® (pertuzumab)
0 Comments
Mark Dybul testifies before a Senate Appropriations State, Foreign Operations and Related Programs Subcommittee hearing in Dirksen Building on global health problems, May 6, 2015. Tom Williams | CQ Roll Call President Donald Trump‘s decision to cut ties with the World Health Organization due to their response to the coronavirus pandemic will ultimately hurt U.S.
0 Comments
COVID-19 manifests differently in various patients. Some may only suffer the mild form of the disease. Others have it worse since they struggle with the more severe form of the illness. Interestingly, there are people who won’t experience anything even though they have already been infected. But this does not mean that they are spared
0 Comments
An artificial intelligence (AI)–based strategy that mines patients’ medical records over time can identify patterns associated with specific diseases, researchers show. The approach may help identify patients at risk of developing certain conditions and could inform management on the basis of disease and outcome models, Hossein Estiri, PhD, Laboratory of Computer Science, Massachusetts General Hospital,
0 Comments
For many people, wearing sunscreen when going outdoors is a normal thing. That’s because the human skin needs protection against the harmful rays of the sun. However, experts are now saying that we should also wear sunscreen even if we are staying indoors. With the ongoing coronavirus outbreak, many people are homebound. Most are working
0 Comments
Print this page NORTH CHICAGO, Ill., June 26, 2020 /PRNewswire/ – Allergan, an AbbVie Company (NYSE: ABBV), and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company developing a new class of custom-built protein therapeutics known as DARPin® therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter to the Biologics License
0 Comments
casimersen Treatment for Duchenne Muscular Dystrophy Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45 Print this page CAMBRIDGE, Mass., June 26, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today
0 Comments
Print this page CAMBRIDGE, Mass. and TARRYTOWN, N.Y., June 19, 2020 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is approved for all Dupixent indications in patients aged 12 years and older, which includes use in certain patients with atopic dermatitis, asthma and chronic rhinosinusitis with
0 Comments
Jacy and Seth Boyack reopened their Arizona massage spa earlier this month from pandemic-driven closures. But they shut Citrus Massage back down after four days, citing safety concerns from the Covid-19 outbreak.  In an interview Monday on CNBC’s “The Exchange,” Jacy Boyack said that even working the front desk, she felt concerned.  “I’m not a massage
0 Comments
A higher level of early-life cognitive enrichment — such as learning a foreign language, reading and being read to, and playing games like checkers — was tied to a slower rate of late-life cognitive decline, a clinical-pathological longitudinal cohort study showed. This effect occurred partly through an association with lower levels of Alzheimer’s pathology changes,
0 Comments
With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months. “The best we’ve ever done is measles, which is 97 to 98 percent effective,” said Fauci, the director of the National Institute of Allergy and Infectious Diseases. “That would be wonderful if we get there.
0 Comments
Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure, requiring dialysis treatment or kidney transplantation for survival, according to a study in Diabetes Care. Development and progression of kidney disease in type 1 diabetes is associated with higher levels of a chemical in the blood
0 Comments
A new analysis of 16 years of publicly accessible health data on 68.5 million Medicare enrollees provides broad evidence that long-term exposure to fine particles in the air – even at levels below current EPA standards – leads to increased mortality rates among the elderly. Based on the results of five complementary statistical models, including
0 Comments
FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome Print this page EMERYVILLE, Calif., June 25, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved Fintepla (fenfluramine) oral solution, CIV for the
0 Comments
Adenilson Souza Costa, 47 years, and his coworkers wearing protective gear carry a coffin at Vila Formosa Cemetery amidst the coronavirus (COVID-19) pandemic on May 18, 2020 in Sao Paulo, Brazil. Alexandre Schneider | Getty Images The coronavirus has now killed more than 500,000 people around the world as the number of confirmed infections exceeded
0 Comments
Welcome to this week’s edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the Web to help you learn what’s next. Lisa Grabl is president of the locum tenens division of CompHealth, the nation’s largest locum tenens physician staffing company and a leader in permanent and temporary allied healthcare
0 Comments
The Centers for Disease Control and Prevention (CDC) has updated its COVID-19 guidelines to adjust the ages and health problems that could make people more likely to have severe complications. The move comes amid the rising number of younger patients and new studies that show the effects of certain conditions. CDC announced the changes on
0 Comments